Renal excretory responses produced by central administration of opioid agonists in ketamine and xylazine-anesthetized rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 609-616

  Cabral, Antonio M ^a   Varner, Kurt J ^b   Kapusta, Daniel R ^b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ANESTHETIC AGENT; DERMORPHIN; KAPPA OPIATE RECEPTOR; KETAMINE; MU OPIATE RECEPTOR; OPIATE AGONIST; XYLAZINE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR RESPONSE; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DRUG INFUSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY FUNCTION; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM EXCRETION; URINARY EXCRETION; URINE FLOW RATE;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANESTHETICS; ANIMALS; CARDIOVASCULAR PHYSIOLOGY; CARDIOVASCULAR SYSTEM; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; KETAMINE; KIDNEY; MALE; OLIGOPEPTIDES; OPIOID PEPTIDES; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; XYLAZINE;

EID: 0030795431     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BACHMAN, L.: The antidiuretic effects of anesthetic agents. Anesthesiology 16: 939-949, 1955.
2. 2-adrenoceptor blockade decreases sodium and water excretion in the anesthetized rat. Eur. J. Pharmacol. 154: 117-124, 1988.
3. 2) antagonists. J. Pharmacol. Exp. Ther. 255: 264-270, 1990.
4. BROCCARDO, M., ERSPAMER, V., ERSPAMER, G. F., IMPORTA, G., LINARI, G., MELCHIORRI, P. AND MONTECUCCHI, P. C.: Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skins. Br. J. Pharmacol. 73: 625-631, 1981.
5. BROOKS, D. P., EDWARDS, R. M., DENNIS DE PALMA, P., FREDRICKSON, T. A., HIEBLE, J. P. AND GELLAI, M.: The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent. J. Pharmacol. Exp. Ther. 259: 1277-1282, 1991.
6. BROOKS, D. P., GIARDINA, G., GELLAI, M., DONDIO, G., EDWARDS R. M., PETRONE G., DEPALMA, P. D., SBACCHI, M., JUGUS, M., MISIANO, P., WANG, Y-X. AND CLARKE, G. D.: Opiate receptors within the blood-brain barrier mediate kappa agonist-induced water diuresis. J. Pharmacol. Exp. Ther. 266: 164-171, 1993.
7. COWAN A. AND KHUNAWAT, P.: Increased urine output by rats after intracere-broventricular administration of kappa agonists. Ann. NY Acad. Sci. 463: 174-176, 1986.
8. DANESH, S. AND WALKER, L. A.: Effects of central administration of morphine on renal function in conscious rats. J. Pharmacol. Exp. Ther. 244: 640-645, 1988.
9. 2-adrenergic agonists on renal function in Long-Evans and Brattleboro rats. Pharmacology 39: 240-252, 1989.
10. DEBODO, R. C. AND PRESCOTT, K. F.: The antidiuretic action of barbiturates (phenobarbital, amytal, pentobarbital) and the mechanism involved in the action. J. Pharmacol. Exp. Ther. 85: 222-233, 1945.
11. DEUTSCH, S., BASTRON, R. D., PIERCE JR., E. C. AND VANDAM, L. D.: The effects of anaesthesia with thiopentone, nitrous oxide, narcotics and neuromuscular blocking drugs on renal function in normal man. Br. J. Anaesth. 41: 807-815, 1969.
12. GELLAI, M. AND RUFFOLO, R. R., JR.: Renal effects of selective alpha-1 and alpha-2 adrenoceptor agonists in conscious, normotensive rats. J. Pharmacol. Exp. Ther. 240: 723-728, 1987.
13. HUIDOBRO-TORO, J. P. AND HUIDOBRO, F.: Central effects of morphine, levorphanol, (-)-methadone, and the opioid-like peptides β-endorphin and D-alanine-methionine enkephalinamide on urine volume outflow and electrolytes. J. Pharmacol. Exp. Ther. 217: 579-585, 1981.
14. KAPUSTA, D. R.: Opioid Mechanisms controlling renal function. Clin. Exp. Pharmacol. Physiol. 22: 891-902, 1995.
15. KAPUSTA, D. R. AND OBIH, J. C.: Central kappa opioid receptor-evoked changes in renal function in conscious rats: Participation of renal nerves. J. Pharmacol. Exp. Ther. 267: 197-204, 1993.
16. KAPUSTA, D. R., OBIH, J. C. AND DIBONA, G. F.: Central mu-opioid receptor mediated changes in renal function in conscious rats. J. Pharmacol. Exp. Ther. 265: 134-143, 1993.
17. KLINE, R. L. AND MERCER, P. F.: Contribution of renal nerves to the natriuretic and diuretic effect of alpha-2 adrenergic receptor activation. J. Pharmacol. Exp. Ther. 253: 266-271, 1990.
18. KLINE, R. L., VAN DER MARK, J. AND CECHETTO, D. F.: Natriuretic effect of rilmenidine in anesthetized rats. Am. J. Cardiol. 74: 20A-24A, 1994.
19. MADDOX, D. A., PRICE, D. C. AND RECTOR, F. C.: Effects of surgery on plasma volume and salt and water excretion in rats. Am. J. Physiol. 233: F600-F606, 1977.
20. MAZZE, R. I., SCHWARTZ, F. D., SLOCUM, H. C. AND BARRY, K. G.: Renal function during anesthesia and surgery. The effects of halothane anesthesia. Anesthesiology 24: 279-284, 1963.
21. MILLER, M.: Clonidine-induced diuresis in the rat: Evidence for a renal site of action J. Pharmacol. Exp. Ther. 214: 608-613, 1980.
22. PAPPER, S., BELSKY, J. L., BLEIFER, K. H., SAXON, L. AND SMITH, W. P.: Effect of meperidine and secobarbital upon renal excretion of water and solute in man. J. Lab. Clin. Med. 56: 727-733, 1960.
23. PAPPER, S. AND PAPPER, E. M.: The effect of preanesthetic, anesthetic, and postoperative drugs on renal function. Clin. Pharmacol. Ther. 5: 206-215, 1964.
24. PAXINOS, G. AND WATSON, C.: The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, Perth, Western Australia, 1986.
25. ROMAN, R. J., COWLEY, A. W., JR. AND LECHENE, C.: Water diuretic and natriuretic effect of clonidine in the rat. J. Pharmacol. Exp. Ther. 211: 385-393, 1979.
26. 8]-dynorphin-A-(1-8) ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J. Pharmacol. Exp. Ther. 262: 979-986, 1992.
27. SALAS, S. P., ROBLERO, J., URETA H. AND HUIDOBRO-TORO, J. P.: Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action. J. Pharmacol. Exp. Ther. 250: 992-999, 1989.
28. SLIZGI, G. R., TAYLOR, C. J. AND LUDENS, J. H.: Effects of the highly selective kappa-opioid U50,488 on renal function in the anesthetised dog. J. Pharmacol. Exp. Ther. 230: 641-645, 1984.
29. +, and water excretion. Am. J. Physiol. 252: F1016-F1021, 1985.
30. STRANDHOY, J. W.: Role of alpha-2 receptors in regulation of renal function, J. Cardiovasc. Pharmacol. 7: S28-S33, 1985.
31. STRANDHOY, J. W., MORRIS, M. AND BUCKALEW, V. M., JR.: Renal effects of the antihypertensive, guanabenz, in the dog. J. Pharmacol. Exp. Ther. 221: 347-352, 1982.
32. TSENG, L-F., LOH, H. H. AND LI, C. H.: β-Endorphin: Antidiuretic effects in rats. Int. J. Pept. Protein Res. 12: 173-176, 1978.
33. WALLENSTEIN, S., ZUCKER, C. L. AND FLEISS, J. L.: Some statistical methods useful in circulation research. Circ. Res. 47: 1-9, 1980.